Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid

Clandinin, Michael T.; Aerde, John E. Van; Merkel, Kimberly L.; Harris, Cheryl L.; Springer, Mary A.; Hansen, James; Diersen-Schade, Deborah A.

doi:10.1016/j.jpeds.2004.11.030

Cited by 223 publications

(170 citation statements)

References 27 publications

Supporting

Mentioning

163

Contrasting

Unclassified

Order By: Relevance

“…6,10 Recent advances in infant formulas and human milk fortifiers have been shown to enhance weight gain beyond that seen a decade ago. 11,12 Moreover, shorter initial 'NPO' periods and more consistent enteral Table 3 Pattern of early weight loss, and subsequent gain, among NICU patients in birth weight categories ranging from 500 to 2500 g, as predicted using four postnatal growth grids (48) 10 (28) The columns display the number of days required to gain 100 g above birth weight, and in parentheses are shown the number of days required to gain 300 g above birth weight. NA ¼ Not applicable (reported only 500-1500 g range).…”

Section: Discussionmentioning

confidence: 99%

“…[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] On the basis of these, we hypothesized that NICU patients cared for currently have more rapid weight gain than are displayed on the commonly used postnatal grids. [2][3][4][5] To test this we collected, from electronic records, all daily weights of all patients with birth weights 400-2600 g, born during a 30-month period, January 1, 2003-June 30, 2005, cared for in any the NICU's of the Intermountain Health Care (IHC) System.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pattern of daily weights among low birth weight neonates in the neonatal intensive care unit: data from a multihospital health-care system

et al. 2005

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Pattern of daily weights among low birth weight neonates in the neonatal intensive care unit: data from a multihospital health-care system

et al. 2005

View full text Add to dashboard Cite

“…Eighteen of these studies were RCTs. [11][12][13][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] Among nonrandomized studies, 4 were interventional studies with a control group [30][31][32][33] and the remaining 2 studies 8,34 did not test an intervention because they examined the association of BPD with LCPUFA concentrations in blood or in tracheal aspirates. Fifteen RCTs presented dichotomous outcomes.…”

Section: Overview Of Included Studiesmentioning

confidence: 99%

Omega-3 Long-Chain Polyunsaturated Fatty Acids for Extremely Preterm Infants: A Systematic Review

et al. 2014

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVE: Omega-3 long chain polyunsaturated fatty acid (LCPUFA) exposure can be associated with reduced neonatal morbidities. We systematically review the evidence for the benefits of omega-3 LCPUFAs for reducing neonatal morbidities in extremely preterm infants.METHODS: Data sources were PubMed, Embase, Center for Reviews and Dissemination, and the Cochrane Register of Controlled Trials. Original studies were selected that included infants born at ,29 weeks' gestation, those published until May 2013, and those that evaluated the relationship between omega-3 LCPUFA supplementation and major adverse neonatal outcomes. Data were extracted on study design and outcome. Effect estimates were pooled. RESULTS:Of the 1876 studies identified, 18 randomized controlled trials (RCTs) and 6 observational studies met the defined criteria. No RCT specifically targeted a population of extremely preterm infants. Based on RCTs, omega-3 LCPUFA was not associated with a decreased risk of bronchopulmonary dysplasia in infants overall (pooled risk ratio [RR] 0.97, 95% confidence interval [CI] 0.82-1.13], 12 studies, n = 2809 infants); however, when considering RCTs that include only infants born at #32 weeks' gestation, a trend toward a reduction in the risk of bronchopulmonary dysplasia (pooled RR 0.88, 95% CI 0.74-1.05, 7 studies, n = 1156 infants) and a reduction in the risk of necrotizing enterocolitis (pooled RR 0.50, 95% CI 0.23-1.10, 5 studies, n = 900 infants) was observed with LCPUFA.CONCLUSIONS: Large-scale interventional studies are required to determine the clinical benefits of omega-3 LCPUFA, specifically in extremely preterm infants, during the neonatal period. Dr Marc conceptualized and designed the protocol, screened the titles and abstracts, and retrieved articles for inclusion and quality, performed the analyses, drafted the initial manuscript, and approved the final manuscript as submitted; Ms Zhang critically reviewed the protocol, screened the titles and abstracts and retrieved articles for inclusion and quality, drafted the tables and figures, and reviewed the final manuscript as submitted; Dr Lavoie screened the articles for quality, revised the manuscript, participated in the redaction of the final manuscript, and reviewed the final manuscript as submitted; Dr Rhainds designed and conducted the systematic database search, reviewed the manuscript, and approved the final manuscript as submitted; and Dr Lacaze-Masmonteil reviewed the manuscript and approved the final manuscript as submitted.www.pediatrics.org/cgi

show abstract

“…По результа-там метаанализа, у детей, получавших молочную смесь, обогащенную ДЦПНЖК, индекс нервно-психического развития по шкале Бейли был на 3 пункта выше, чем у детей группы сравнения, вскармливавшихся необога-щенным продуктом [55,56].…”

Section: обзор литературыunclassified

Long-Chain Polyunsaturated Fatty Acids and Their Role in Children Nourishment

Боровик¹,

Грибакин²,

Скворцова³

et al. 2012

Vopr. sovr. pediatr.

View full text Add to dashboard Cite

Несомненным достижением нутрициологии в пос-ледней четверти ХХ в. являются результаты детального изучения роли длинноцепочечных полиненасыщенных жирных кислот (ДЦПНЖК) в питании человека и в осо-бенности их значение в метаболизме и развитии мозга у детей первого года жизни [1,2]. Отправной точкой при проведении исследований в этом направлении послужили данные об их содержании в грудном молоке [3][4][5]. Было установлено, что грудное молоко содержит относительно низкие концентрации короткоцепочечных жирных кислот и в то же время -значительные количе-ства ДЦПНЖК, в частности арахидоновой (АК) и докоза-гексаеновой (ДГК) [6,7].Показано, что содержание АК в грудном молоке составляет 0,3-0,6%, и ее концентрация относительно стабильна в различных регионах мира, причем не имеет тесной связи с питанием матери. Напротив, содержа-ние ДГК варьирует в достаточно широком диапазоне (от 0,1 до 1,0%) и хорошо коррелирует с содержанием этой кислоты в рационе кормящей женщины [8,9].Важно отметить, что содержание ДЦПНЖК в грудном молоке матерей, родивших недоношенных детей, выше, чем в таковом у женщин после срочных родов [10]. Установлено положительное влияние дополнительного введения АК и ДГК в состав детских молочных смесей на когнитивное развитие и остроту зрения у недоношен-ных детей, а также, хотя и в меньшей степени, у детей, родившихся в срок [11].Известно, что для детей первого года жизни харак-терны быстрый рост и развитие. Поэтому их рацион дол-жен включать в оптимальных количествах и сбаланси-рованных соотношениях основные пищевые вещества,

show abstract

Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid

Cited by 223 publications

References 27 publications

Pattern of daily weights among low birth weight neonates in the neonatal intensive care unit: data from a multihospital health-care system

Pattern of daily weights among low birth weight neonates in the neonatal intensive care unit: data from a multihospital health-care system

Omega-3 Long-Chain Polyunsaturated Fatty Acids for Extremely Preterm Infants: A Systematic Review

Long-Chain Polyunsaturated Fatty Acids and Their Role in Children Nourishment

Contact Info

Product

Resources

About